Modified gamma camera zeroes in on subcentimeter breast lesions

Article

Researchers at the Mayo Clinic in Rochester, MN, have developed a molecular breast imaging technique that uses a cadmium-zinc-telluride semiconductor detector.

Researchers at the Mayo Clinic in Rochester, MN, have developed a molecular breast imaging technique that uses a cadmium-zinc-telluride semiconductor detector.

The investigators mounted a gamma camera, which has a field-of-view of 20 x 20 cm and detector elements of 2.5 x 2.5 mm, onto a modified mammographic gantry. Between November 2001 and March 2004, they imaged 40 women who were scheduled for biopsy. The study was published in the January issue of the Mayo Clinic Proceedings.

Using 20 mCi of technetium-99m sestamibi, they obtained craniocaudal and mediolateral oblique views of both breasts. The imaging technique detected 33 of 36 lesions confirmed to be malignant by surgery, for an overall sensitivity of 92%. It detected 19 of 22 surgery-confirmed lesions smaller than 1 cm, for a sensitivity of 86%.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.